Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

Iterum Therapeutics plc (ITRM) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $0.45 Metrics
OS: 13.0 M
Market cap: $5.92 M
Net cash: $33.1 M $2.54 per share
EV:

 
TTM Valuation
EBITDA
EBIT ($38.7) M
EPS

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16
Revenues0.00.00.00.00.90.50.0
            Revenue growth  -100.0%-95.7%71.1%  
Cost of goods sold0.00.00.00.00.00.00.0
Gross profit0.00.00.00.00.90.50.0
            Gross margin   100.0%100.0%100.0% 
Selling, general and administrative30.424.532.1    
Research and development   90.868.625.510.1
General and administrative   11.38.84.53.3
EBITA-40.1-85.9-50.5-102.0-76.6-29.5-13.4
            EBITA margin   -275732.4%-8810.0%-5798.2% 
Amortization of intangibles1.71.7     
EBIT-41.9-87.6-50.5-102.0-76.6-29.5-13.4
            EBIT margin   -275732.4%-8810.0%-5798.2% 
Pre-tax income-44.1-90.9-51.3-102.7-76.6-29.0-13.4
Income taxes0.30.70.70.40.50.40.1
Net income-44.4-91.6-52.0-103.1-77.1-29.4-13.5
            Net margin   -278729.7%-8867.2%-5788.6% 
 
Diluted EPS($3.63)($8.41)($32.49)($7.10)($8.82)($170.84)($568.87)
Shares outstanding (diluted)12.210.91.614.58.70.20.0
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy